How can we improve stroke thrombolysis rates? A review of health system factors and approaches associated with thrombolysis administration rates in acute stroke care

Implementation Science

Volumn 11, Issue 1, 2016, Pages

  Paul, Christine L ^a,c   Ryan, Annika ^a,c   Rose, Shiho ^a,c   Attia, John R ^a,c   Kerr, Erin ^b   Koller, Claudia ^a,c   Levi, Christopher R ^a,b,c  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b Hunter New England Area Health Service   (Australia)

^c HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Health system change; Implementation; Ischemic stroke; Quality improvement; Thrombolysis; Tissue plasminogen activator

Indexed keywords

FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; FIBRINOLYTIC THERAPY; HEALTH CARE DELIVERY; HUMAN; INTENSIVE CARE; PROCEDURES; STROKE;

ACUTE DISEASE; CRITICAL CARE; DELIVERY OF HEALTH CARE; FIBRINOLYTIC AGENTS; HUMANS; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84962657036     PISSN: None     EISSN: 17485908     Source Type: Journal    
DOI: 10.1186/s13012-016-0414-6     Document Type: Article

References (79)

1. Lopez AD, Mathers CD, Ezatti M, Jamieson DT, Murray DJL. Global burden of disease and risk factors. New York/Washington: Oxford University Press and the World Bank; 2006.
2. Mackay J, Mensah G. The atlas of heart disease and stroke. Geneva: WHO; 2004.
3. Agency for Healthcare Research and Quality. Household component summary table. In: Medical Expenditure Panel Survey. U.S. Department of Health and Human Services. 2012. http://meps.ahrq.gov/mepsweb/. Accessed 12 Nov 2012.
4. Australian Bureau of Statistics. Cardiovascular disease in Australia: a snapshot, 2004-05. Canberra: ABS; 2006.
5. Australian Institute of Health and Welfare. Australia's health 2006. Report. Canberra: AIHW; 2006. Report No.:1032-6138.
6. Deloitte Access Economics. The economic impact of stroke in Australia. Melbourne: NSF; 2013.
7. National Stroke Foundation. National stroke audit-acute services clinical audit report 2011. Report. Melbourne: NSF; 2011.
8. Hankey GJ, Jamrozik K, Broadhurst RJ, Forbes S, Anderson CS. Long-term disability after first-ever stroke and related prognostic factors in the Perth Community Stroke Study, 1989-1990. Stroke. 2002;33(4):1034-40.
9. Saver J, Fonarow G, Smith E, Reeves M, Grau-Sepulveda M, Pan W, et al. Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA. 2013;309(23):2480-8.
10. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5hours after acute ischemic stroke. N Engl J Med. 2008;359(13):1317-29.
11. Ahmed N, Wahlgren N, Grond M, Hennerici M, Lees KR, Mikulik R, et al. Implementation and outcome of thrombolysis with alteplase 3-4.5h after an acute stroke: an updated analysis from SITS-ISTR. Lancet Neurol. 2010;9(9):866-74.
12. Strbian D, Michel P, Ringleb P, Numminen H, Breuer L, Bodenant M, et al. Relationship between onset-to-door time and door-to-thrombolysis time: a pooled analysis of 10 dedicated stroke centers. Stroke. 2013;44(10):2808-13.
13. Quain DA, Parsons MW, Loudfoot AR, Spratt NJ, Evans MK, Russell ML, et al. Improving access to acute stroke therapies: a controlled trial of organised pre-hospital and emergency care. Med J Aust. 2008;189(8):429-33.
14. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008;337.
15. Bunch ME, Nunziato EC, Labovitz DL. Barriers to the use of intravenous tissue plasminogen activator for in-hospital strokes. J Stroke Cerebrovasc Dis. 2012;21(8):808-11.
16. Johnson M, Bakas T. A review of barriers to thrombolytic therapy: implications for nursing care in the emergency department. J Neurosci Nurs. 2010;42(2):88-94.
17. Kwan J, Hand P, Sandercock P. A systematic review of barriers to delivery of thrombolysis for acute stroke. Age Ageing. 2004;33(2):116-21.
18. Upchurch GR, Dimick JB, Wainess RM, Eliason JL, Henke PK, Cowan JA, et al. Diffusion of new technology in health care: the case of aorto-iliac occlusive disease. Surgery. 2004;136(4):812-8.
19. Jaffe AB, Newell RG, Stavins RN. A tale of two market failures: technology and environmental policy. Ecol Econ. 2005;54(2):164-74.
20. Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6(1):42.
21. Adeoye O, Hornung R, Khatri P, Kleindorfer D. Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5years. Stroke. 2011;42(7):1952-5.
22. Bergman M, Ori Y, Blumberger N, Salman H. An alternative facility for a stroke unit in a community hospital. Eur J Intern Med. 2011;22(5):505-8.
23. Dick AP, Straka J. IV tPA for acute ischemic stroke: results of the first 101 patients in a community practice. Neurologist. 2005;11(5):305-8.
24. Slaght SJ, Weir NU, Lovett JK. The workload of stroke thrombolysis: a prospective study in a district general hospital setting. Acute Med. 2011;10(1):10-2.
25. Douglas VC, Tong DC, Gillum LA, Zhao S, Brass LM, Dostal J, et al. Do the brain attack coalition's criteria for stroke centers improve care for ischemic stroke? Neurology. 2005;64(3):422-7.
26. Prabhakaran S, McNulty M, O'Neill K, Ouyang B. Intravenous thrombolysis for stroke increases over time at primary stroke centers. Stroke. 2012;43(3):875-7.
27. Ranta A, Chan C, Rump D, Cariga P, Anderson L. Safety and efficacy of stroke thrombolysis at a secondary provincial hospital in New Zealand. N Z Med J. 2012;125(1358):35-43.
28. Salami S, Kolluru A, Al-Najafi S, Stover C, Mar A, Szpunar S, et al. Utilization and outcome of thrombolytic therapy for acute ischemic stroke: the St. John Hospital code stroke experience. J Clin Outcomes Manag. 2011;18(4):165-9.
29. Moynihan B, Davis D, Pereira A, Cloud G, Markus HS. Delivering regional thrombolysis via a hub-and-spoke model. J R Soc Med. 2010;103(9):363-9.
30. Nelson RE, Saltzman GM, Skalabrin EJ, Demaerschalk B, Majersik JJ. The cost-effectiveness of telestroke in the treatment of acute ischemic stroke. Neurology. 2011;77(17):1590-8.
31. Schwamm LH, Audebert HJ, Amarenco P, Chumbler NR, Frankel MR, George MG, et al. Recommendations for the implementation of telemedicine within stroke systems of care: a policy statement from the American Heart Association. Stroke. 2009;40:2635-60.
32. Schwamm LH, Fonarow GC, Reeves MJ, Pan W, Frankel MR, Smith EE, et al. Get With The Guidelines-Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack. Circulation. 2009;119(1):107-15.
33. van Wijngaarden JDH, Dirks M, Niessen LW, Huijsman R, Dippel DWJ. Do centres with well-developed protocols, training and infrastructure have higher rates of thrombolysis for acute ischemic stroke? QJM. 2011;104(9):785-91.
34. FDA. Alteplase product approval information-licensing action 6/18/96. 04/02/2009 ed: U.S. Food and Drug Administration; 1996.
35. Adams HP, Brott TG, Furlan AJ, Gomez CR, Grotta J, Helgason CM, et al. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke: a statement for healthcare professionals from a special writing group of the stroke council. Am Heart Assoc Circ. 1996;94(5):1167-74.
36. Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M, et al. Guidance on the conduct of narrative synthesis in systematic reviews, A product from the ESRC methods programme version. 2006. p. 1.
37. American Heart Association. Get With The Guidelines-Stroke. 2014. http://www.heart.org/HEARTORG/HealthcareResearch/GetWithTheGuidelines/Get-With-The-Guidelines-Stroke_UCM_306098_SubHomePage.jsp. Accessed 10 Jan 2014.
38. Demaerschalk BM, Bobrow BJ, Raman R, Kiernan T-EJ, Aguilar MI, Ingall TJ, et al. Stroke team remote evaluation using a digital observation camera in Arizona: the initial Mayo Clinic experience trial. Stroke. 2010;41(6):1251-8.
39. Meyer BC, Raman R, Hemmen T, Obler R, Zivin JA, Rao R, et al. Efficacy of site-independent telemedicine in the STRokE DOC trial: a randomised, blinded, prospective study. Lancet Neurol. 2008;7(9):787-95.
40. Theiss S, Günzel F, Storm A, Hausn P, Isenmann S, Klisch J, et al. Using routine data for quality assessment in NeuroNet telestroke care. J Stroke Cerebrovasc Dis. 2013;22(7):984-90.
41. Dirks M, Koudstaal PJ, Dippel DWJ, Niessen LW, van Wijngaarden JDH, Franke CL, et al. Effectiveness of thrombolysis with intravenous alteplase for acute ischemic stroke in older adults. J Am Geriatr Soc. 2011;59(11):2169-71.
42. Morgenstern LB, Bartholomew LK, Grotta JC, Staub L, King M, Chan W. Sustained benefit of a community and professional intervention to increase acute stroke therapy. Arch Intern Med. 2003;163(18):2198-202.
43. Scott PA, Meurer WJ, Frederiksen SM, Kalbfleisch JD, Xu Z, Haan MN, et al. A multilevel intervention to increase community hospital use of alteplase for acute stroke (INSTINCT): a cluster-randomised controlled trial. Lancet Neurol. 2013;12(2):139-48.
44. Fonarow GC, Smith EE, Saver JL, Reeves MJ, Hernandez AF, Peterson ED, et al. Improving door-to-needle times in acute ischemic stroke: the design and rationale for the American Heart Association/American Stroke Association's target: stroke initiative. Stroke. 2011;42(10):2983-9.
45. Power M, Tyrrell PJ, Rudd AG, Tully MP, Dalton D, Marshall M, et al. Did a quality improvement collaborative make stroke care better? A cluster randomized trial. Implement Sci. 2014;9(40):9pp.
46. Demaerschalk BM, Raman R, Ernstrom K, Meyer BC. Efficacy of telemedicine for stroke: pooled analysis of the Stroke Team Remote Evaluation Using a Digital Observation Camera (STRokE DOC) and STRokE DOC Arizona telestroke trials. Telemed J E Health. 2012;18(3):230-7.
47. Atun R. Health systems, systems thinking and innovation. Health Policy Plan. 2012;27 suppl 4:iv4-8.
48. Kunisawa S, Morishima T, Ukawa N, Ikai H, Otsubo T, Ishikawa KB, et al. Association of geographical factors with administration of tissue plasminogen activator for acute ischemic stroke. J Am Heart Assoc. 2013;2(5), e000336.
49. Hsieh CY, Chen CH, Chen YC, Kao Yang YH. National survey of thrombolytic therapy for acute ischemic stroke in Taiwan 2003-2010. J Stroke Cerebrovasc Dis. 2013;22(8):e620-7.
50. Kunisawa S, Kobayashi D, Lee J, Otsubo T, Ikai H, Yokota C, et al. Factors associated with the administration of tissue plasminogen activator for acute ischemic stroke. J Stroke Cerebrovasc Dis. 2014;23(4):724-31.
51. Albright KC, Schott TC, Jafari N, Wohlford-Wessels MP, Finnerty EP, Jacoby MRK. Tissue plasminogen activator use: Evaluation and initial management of ischemic stroke from an Iowa Hospital perspective. J Stroke Cerebrovasc Dis. 2005;14(3):127-35.
52. Leyden JM, Chong WK, Kleinig T, Lee A, Field JB, Jannes J. A population-based study of thrombolysis for acute stroke in South Australia. Med J Aust. 2011;194(3):111-5.
53. Acharya AB, Nyirenda JC, Higgs GB, Bloomfield MS, Cruz-Flores S, Connor LT, et al. Distance from home to hospital and thrombolytic utilization for acute ischemic stroke. J Stroke Cerebrovasc Dis. 2011;20(4):295-301.
54. Kozera G, Chwojnicki K, Gojska-Grymajło A, Gasecki D, Schminke U, Nyka WM. Pre-hospital delays and intravenous thrombolysis in urban and rural areas. Acta Neurol Scand. 2012;126:171-7.
55. Nasr DM, Brinjikji W, Cloft HJ, Rabinstein AA. Utilization of intravenous thrombolysis is increasing in the United States. Int J Stroke. 2013;8(8):681-8.
56. Reed SD, Cramer SC, Blough DK, Meyer K, Jarvik JG. Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals. Stroke. 2001;32(8):1832-40.
57. Lahr MMH, Luijckx G-J, Vroomen PCAJ, van der Zee D-J, Buskens E. Proportion of patients treated with thrombolysis in a centralized versus a decentralized acute stroke care setting. Stroke. 2012;43(5):1336-40.
58. Charipar R, Charipar E. Administration of tissue plasminogen activator for acute ischemic stroke in a rural Wisconsin hospital. Wis Med J. 2008;107(4):176-80.
59. Wang Y, Liao X, Zhao X, Wang DZ, Wang C, Nguyen-Huynh MN, et al. Using recombinant tissue plasminogen activator to treat acute ischemic stroke in China: analysis of the results from the Chinese National Stroke Registry (CNSR). Stroke. 2011;42(6):1658-64.
60. Eriksson M, Jonsson F, Appelros P, Asberg KH, Norrving B, Stegmayr B, et al. Dissemination of thrombolysis for acute ischemic stroke across a nation: experiences from the Swedish stroke register, 2003 to 2008. Stroke. 2010;41(6):1115-22.
61. Heuschmann PU, Berger K, Misselwitz B, Hermanek P, Leffmann C, Adelmann M, et al. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group. Stroke. 2003;34(5):1106-13.
62. Jeng J-S, Tang S-C, Deng I-C, Tsai L-K, Yeh S-J, Yip P-K. Stroke center characteristics which influence the administration of thrombolytic therapy for acute ischemic stroke: a national survey of stroke centers in Taiwan. J Neurol Sci. 2009;281:24-7.
63. Kansara A, Chaturvedi S, Bhattacharya P. Thrombolysis and outcome of young stroke patients over the last decade: insights from the Nationwide Inpatient Sample. J Stroke Cerebrovasc Dis. 2013;22(6):799-804.
64. Nilanont Y, Nidhinandana S, Suwanwela NC, Hanchaiphiboolkul S, Pimpak T, Tatsanavivat P, et al. Quality of acute ischemic stroke care in Thailand: a prospective multicenter countrywide cohort study. J Stroke Cerebrovasc Dis. 2014;23(2):213-9.
65. Hills NK, Johnston SC. Why are eligible thrombolysis candidates left untreated? Am J Prev Med. 2006;31(6 Suppl 2):S210-6.
66. Bray BD, Campbell J, Cloud GC, Hoffman A, Tyrrell PJ, Wolfe CDA, et al. Bigger, faster?: associations between hospital thrombolysis volume and speed of thrombolysis administration in acute ischemic stroke. Stroke. 2013;44(11):3129-35.
67. Engelter ST, Gostynski M, Papa S, Ajdacic-Gross V, Lyrer PA. Barriers to stroke thrombolysis in a geographically defined population. Cerebrovasc Dis. 2007;23(2-3):211-5.
68. Moradiya Y, Crystal H, Valsamis H, Levine SR. Thrombolytic utilization for ischemic stroke in US hospitals with neurology residency program. Neurology. 2013;81(23):1986-95.
69. Fang MC, Cutler DM, Rosen AB. Trends in thrombolytic use for ischemic stroke in the United States. J Hosp Med. 2010;5(7):406-9.
70. Madej-Fermo OP, Staff I, Fortunato G, Abbott L, McCullough LD. Impact of emergency department transitions of care on thrombolytic use in acute ischemic stroke. Stroke. 2012;43(4):1067-74.
71. Hoh BL, Chi Y-Y, Waters MF, Mocco J, Barker 2nd FG. Effect of weekend compared with weekday stroke admission on thrombolytic use, in-hospital mortality, discharge disposition, hospital charges, and length of stay in the Nationwide Inpatient Sample Database, 2002 to 2007. Stroke. 2010;41(10):2323-8.
72. Keyhani S, Arling G, Williams LS, Ross JS, Ordin DL, Myers J, et al. The use and misuse of thrombolytic therapy within the Veterans Health Administration. Med Care. 2012;50(1):66-73.
73. Iguchi Y, Kimura K, Watanabe M, Shibazaki K, Aoki J. Utility of the Kurashiki prehospital stroke scale for hyperacute stroke. Cerebrovasc Dis. 2011;31(1):51-6.
74. McKinney JS, Mylavarapu K, Lane J, Roberts V, Ohman-Strickland P, Merlin MA. Hospital prenotification of stroke patients by emergency medical services improves stroke time targets. J Stroke Cerebrovasc Dis. 2013;22(2):113-8.
75. Lin CB, Peterson ED, Smith EE, Saver JL, Liang L, Xian Y, et al. Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke. Circ Cardiovasc Qual Outcomes. 2012;5(4):514-22.
76. Nagaraja N, Bhattacharya P, Norris G, Coplin W, Narayanan S, Xavier A, et al. Arrival by ambulance is associated with acute stroke intervention in young adults. J Neurol Sci. 2012;316(1-2):168-9.
77. Mullen MT, Kasner SE, Kallan MJ, Kleindorfer DO, Albright KC, Carr BG. Joint commission primary stroke centers utilize more rt-PA in the nationwide inpatient sample. J Am Heart Assoc. 2013;2(2):e000071. doi: 10.1161/JAHA.112.000071.
78. Joux J, Olindo S, Girard-Claudon A, Chausson N, Saint-Vil M, Signate A, et al. Prehospital transfer medicalization increases thrombolysis rate in acute ischemic stroke. A French stroke unit experience. Clin Neurol Neurosurg. 2013;115(9):1583-5.
79. Ekundayo OJ, Saver JL, Fonarow GC, Schwamm LH, Xian Y, Zhao X, et al. Patterns of emergency medical services use and its association with timely stroke treatment findings from Get With The Guidelines-Stroke. Circ Cardiovasc Qual Outcomes. 2013;6(3):262-9.